Pharmaceutical

VC firm Vivo Capital outlays $740m for biotech investment

Vivo Capital has previously backed biotechs acquired by big pharma in billion-dollar deals.

May 10, 2025 - 06:00
VC firm Vivo Capital outlays $740m for biotech investment
Vivo Capital has previously backed biotechs acquired by big pharma in billion-dollar deals.
Read the original article

Tags:

Previous Article

Viralgen and Trogenix to progress gene therapy for glioblastoma

Next Article

BioVaxys and Sona partner to develop cancer therapeutics

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

The Biden administration will hang on to some Covid pandemic emergency powers

The Biden administration will hang on to some Covid pan...

Apr 15, 2023

Higher naloxone doses have no impact on overdose survival, study shows

Higher naloxone doses have no impact on overdose surviv...

Feb 9, 2024

Revenue growth for 13 of top 20 biopharmas with obesity drug successes in 2023

Revenue growth for 13 of top 20 biopharmas with obesity...

Aug 1, 2024